Uncovering the Relationship Between Statins and Muscle Problems in the ELSA-Brasil MSK Cohort
Authors:
- Aline Fernandes PedrosoAPAline Fernandes Pedroso
- Sandhi Maria BarretoSBSandhi Maria Barreto
- Rosa Weiss TellesRTRosa Weiss Telles
- Luciana A. C. MachadoLMLuciana A. C. Machado
- Maria de Fátima Haueisen Sander DinizMDMaria de Fátima Haueisen Sander Diniz
- Bruce Bartholow DuncanBDBruce Bartholow Duncan
- Roberta Carvalho FigueiredoRFRoberta Carvalho Figueiredo
- 1 June 2023
- journal article
- research article
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 38 (6) , 1409-1414
Abstract
Purpose To investigate the association between statins and muscle problems in a highly diverse sample of Brazilian civil servants. Methods We conducted a cross-sectional data analysis at baseline of the ELSA-Brasil MSK cohort. Pain was identified through self-reported symptoms in large muscle groups (lower back and/or hips/thighs). Muscle strength was assessed using the five-times-sit-to-stand (FTSTS) and handgrip tests, with weakness defined as the lowest and highest quintiles of age- and sex-stratified handgrip strength and FTSTS performance time, respectively. Multivariable logistic regression analyses were conducted to investigate the association between statin use and muscle pain and weakness. Secondary analyses explored the impact of different types of statins and their duration of use on the response variables. Results A total of 2156 participants (mean age 55.6 ± SD 8.9, 52.8% women) were included, of whom 21.1% were taking statins and 25.1% reported muscle pain. We found no significant association between statin use and muscle problems. Secondary analysis on different types of statins revealed an association between atorvastatin and muscle weakness, as measured by the five-times-sit-to-stand test (OR 1.94, 95% CI 1.12–3.37), but not by the handgrip test (OR 0.75, 95% CI 0.29–1.42). No evidence was found to support a link between the duration of statin treatment and muscle problems. Conclusions This study challenges previous claims of an efficacy-effectiveness gap between experimental and observational literature on statins. The findings indicate that statin use does not contribute to muscular problems.Keywords
All Related Versions
This publication has 14 references indexed in Scilit:
- Cardiovascular profile in osteoarthritis: a meta-analysis of cardiovascular events and risk factorsJoint Bone Spine, 2019
- Statin use in Brazil: findings and implicationsCurrent Medical Research and Opinion, 2018
- A systematic literature review on the efficacy–effectiveness gap: comparison of randomized controlled trials and observational studies of glucose-lowering drugsClinical Epidemiology, 2017
- Interpretation of the evidence for the efficacy and safety of statin therapyThe Lancet, 2016
- Cardiovascular Health in BrazilCirculation, 2016
- Does selection bias explain the obesity paradox among individuals with cardiovascular disease?Annals of Epidemiology, 2015
- Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam studyAnnals of the Rheumatic Diseases, 2012
- Statin Use and Musculoskeletal Pain Among Adults With and Without ArthritisThe American Journal of Medicine, 2012
- Prevalence of Musculoskeletal Pain and Statin UseJournal of General Internal Medicine, 2008
- Statin-related adverse events: A meta-analysisClinical Therapeutics, 2006